JCP

eISSN 2288-3657
pISSN 2288-3649

Table 4.

Fecal calprotectin levels before and after milk consumption

		A2 milk			A1/A2 milk			P-valuec

		Before	After	P-value	Before	After	P-value
Period 1	Total	41.55 ± 20.35	56.07 ± 24.61	0.762^a	20.56 ± 3.66	330.82 ± 299.77	0.464^a	0.030
	Male	83.90 ± 62.97	11.70 ± 2.27	0.313^a	21.88 ± 4.73	25.77 ± 9.21	0.829b	0.005
	Female	23.90 ± 7.39	76.15 ± 34.10	0.232^a	20.05 ± 4.72	424.20 ± 388.33	0.414^a	0.080
Period 2	Total	29.63 ± 10.76	22.04 ± 6.20	0.787^a	109.14 ± 77.94	31.39 ± 11.09	0.225^a	0.218
	Male	43.14 ± 21.74	14.54 ± 3.83	0.373^b	46.00 ± 20.23	21.54 ± 8.21	0.189^b	0.623
	Female	23.91 ± 11.80	24.12 ± 8.09	0.978^b	135.44 ± 109.20	35.50 ± 15.18	0.519^a	0.118

Values are presented as least squares mean ± standard error (mg/kg). Per protocol analysis. Period 1, the consumption period for the first intervention milk; Period 2, the consumption period for the second intervention milk. P-values were calculated using ^aWilcoxon signed rank test, ^bpaired t-test or cgeneralized estimating equation (gamma distribution).

J Cancer Prev 2024;29:45~53 https://doi.org/10.15430/JCP.24.007